bioMerieux Launches First VRE Screening Tool
bioMerieux has announced the launch of the first FDA cleared chromID VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE).
Read MorebioMerieux has announced the launch of the first FDA cleared chromID VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE).
Read MoreAcroMetrixBender MedSystemsThyroTecViroStat
Read MoreBiosearch Technologies Inc announced that the company has expanded its licenses from Roche Molecular Systems. The expanded license grants Biosearch the right to manufacture and sell validated kits to the in-vitro diagnostic (IVD) marketplace as licensed products covered by multiple patents assigned to Roche.
Read MoreAspenBio Pharma Inc, an emerging bio-science company dedicated to the development of novel diagnostics and drugs for humans and animals, announced that it has entered into a strategic manufacturing relationship with BBInternational (“BBI”) to complete commercial development and manufacture of the AppyScore consumable test cassette.
Read MoreCaliper Life SciencesCarl Zeiss
Read More